⌘K

Home/Filings/4/0001104659-22-128765

4//SEC Filing

TUCHMAN ALAN J 4

Accession 0001104659-22-128765

CIK 0001571934other

View on SEC.gov Company Profile

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 8:00 PM ET

Size

4.9 KB

Accession

0001104659-22-128765

Insider Transaction Report

Form 4

Period: 2022-12-16

Synaptogenix, Inc.SNPX

DirectorChief Medical Officer

Transactions

Sale
Common Stock, par value $0.0001 per share
2022-12-16$1.17/sh−27,000$31,641→ 33,000 total

Footnotes (1)

[F1]Shares sold pursuant to a Rule 10b5-1 sales plan, entered into on December 6, 2021 and amended and restated on October 24, 2022, to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

Documents

1 file

4
tm2233089-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Synaptogenix, Inc.

CIK 0001571934

Entity typeother

Related Parties

1

filerCIK 0001417631

Filing Metadata

Form type: 4
Filed: Dec 19, 7:00 PM ET
Accepted: Dec 20, 8:00 PM ET
Size: 4.9 KB

View on SEC.gov